BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15881803)

  • 1. Spectrophotometric determination of captopril with DTNB reagent in pharmaceutical formulation.
    Hosseinimehr SJ; Ebrahimi P; Hassani N; Mirzabeigi P; Amini M
    Boll Chim Farm; 2004; 143(6):249-51. PubMed ID: 15881803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive kinetic spectrophotometric method for the determination of captopril in bulk and dosage forms.
    Rahman N; Anwar N; Kashif M; Hoda N
    Acta Pharm; 2006 Sep; 56(3):347-57. PubMed ID: 19831283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalysis reaction between sodium 1,2-naphthoquinone-4-sulfonate and hydroxyl ion using captopril as catalyzer and determination of captopril.
    Gao L; Wu L; Li Q
    Anal Chim Acta; 2008 Sep; 626(2):174-9. PubMed ID: 18790118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of captopril on a coated capillary by capillary electrophoresis.
    Hillaert S; Van den Bossche W
    J Pharm Belg; 1999; 54(3):83-4. PubMed ID: 10431475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution.
    Huang T; He Z; Yang B; Shao L; Zheng X; Duan G
    J Pharm Biomed Anal; 2006 May; 41(2):644-8. PubMed ID: 16413728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPLC-DAD method for the simultaneous determination of zofenopril and hydrochlorothiazide in oral pharmaceutical formulations.
    Carlucci G; Di Federico L; Iuliani P
    J Sep Sci; 2010 Jun; 33(12):1717-22. PubMed ID: 20437414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of simultaneous volumetric and spectrophotometric methods for the determination of captopril in pharmaceutical formulations.
    Rahman N; Singh M; Hoda N
    Farmaco; 2005; 60(6-7):569-74. PubMed ID: 15927181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting kinetic spectrophotometric determination of captopril, an angiotensin-converting enzyme inhibitor, in a multi-pumping flow system.
    Prior JA; Santos JL; Lima JL
    Anal Chim Acta; 2007 Sep; 600(1-2):183-7. PubMed ID: 17903482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of captopril in biological samples by high-performance liquid chromatography with ThioGlo 3 derivatization.
    Aykin N; Neal R; Yusof M; Ercal N
    Biomed Chromatogr; 2001 Nov; 15(7):427-32. PubMed ID: 11746237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a capillary electrophoresis method with laser-induced fluorescence detection for the determination of captopril in human urine and pharmaceutical preparations.
    Pérez-Ruiz T; Martínez-Lozano C; Galera R
    Electrophoresis; 2006 Jun; 27(12):2310-6. PubMed ID: 16718646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of captopril and prednisolone in tablets by FT-Raman spectroscopy.
    Mazurek S; Szostak R
    J Pharm Biomed Anal; 2006 Mar; 40(5):1225-30. PubMed ID: 16253463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive kinetic spectrophotometric determination of captopril and ethamsylate in pharmaceutical preparations and biological fluids.
    El-Shabrawy Y; El-Enany N; Salem K
    Farmaco; 2004 Oct; 59(10):803-8. PubMed ID: 15474057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrophotometric determination of benazepril in tablets.
    Belal F; Al-Zaagi IA; Abounassif MA
    Farmaco; 2000; 55(6-7):425-32. PubMed ID: 11204742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of uv derivative spectrophotometric method for determination of benazepril hydrochloride in tablets and evaluation of its stability.
    Stanisz B; Paszun S; Leśniak M
    Acta Pol Pharm; 2009; 66(4):343-9. PubMed ID: 19702164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated RP-hPLC method for the assay of zalcitabine in drug substance, formulated products and human serum.
    Uslu B; Savaşer A; Ozkan SA; Ozkan Y
    Pharmazie; 2004 Aug; 59(8):604-7. PubMed ID: 15378847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First order derivative spectrophotometric and HPLC methods for determination of moexipril hydrochloride in the pure form, pharmeceutical formulations and evaluation of its stability.
    Stanisz B; Regulska K; Ratajczak T
    Acta Pol Pharm; 2012; 69(3):389-95. PubMed ID: 22594252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UV derivative spectrophotometric and RP-HPLC methods for determination of imidapril hydrochloride in tablets and for its stability assessment in solid state.
    Stanisz B; Regulska K; Kolasa K
    Acta Pol Pharm; 2011; 68(5):645-51. PubMed ID: 21928708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UV-spectrophotometric determination of imatinib mesylate and its application in solubility studies.
    Bende G; Kollipara S; Sekar V; Saha R
    Pharmazie; 2008 Sep; 63(9):641-5. PubMed ID: 18819515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Photometric determination of captopril using label-free silver nanoparticles].
    Li R; Yan HT
    Guang Pu Xue Yu Guang Pu Fen Xi; 2013 Apr; 33(4):1104-7. PubMed ID: 23841437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of carbon disulphide for the analytical determination of betahistine hydrochloride and captopril in their pharmaceutical preparations.
    El Walily AF; Razak OA; Belal SF; Bakry RS
    J Pharm Biomed Anal; 1999 Nov; 21(2):439-49. PubMed ID: 10704001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.